Gender differences in adverse drug reactions

Journal of Clinical Pharmacology

Volumn 38, Issue 11, 1998, Pages 1003-1009

  Tran, Chau ^a   Knowles, Sandra R ^b   Liu, Barbara A ^b,c   Shear, Neil H ^a,b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b BAYCREST CENTRE FOR GERIATRIC CARE   (Canada)

^c Kunin Lunenfeld Applied Research Unit and Department of Food and Nutrition Services and Baycrest Centre for Geriatric Care   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CENTRAL NERVOUS SYSTEM AGENTS; DERMATOLOGICAL AGENT; ERYTHROMYCIN; PENICILLIN DERIVATIVE; SULFONAMIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DEMOGRAPHY; DRUG EFFECT; DRUG INDUCED DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SKIN TEST;

EID: 0031786048     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/009127009803801103     Document Type: Article

References (37)

1. Venulet J, Ten Ham M: Methods for monitoring and documenting adverse drug reactions. Int J Clin Pharmacol Ther 1996;34:112-129.
2. Caranasos G, Stewart R, Cluff L: Drug-induced illness leading to hospitalization. JAMA 1974;228:713-717.
3. Hurwitz N, Wade OL: Intensive hospital monitoring of adverse reactions to drugs. Br Med J 1969;1:532-536.
4. Klein U, Klein M, Sturm H, Rothebuhler M, Huber R, Stucki P, et al:The frequency of adverse drug reactions as dependent upon age, sex, and duration of hospitalization. Int J Clin Pharmacol 1976;13:187-195.
5. Kenney Gray T, Adams LL, Fallon HJ: Short-term intense surveillance of adverse drug reactions. J Clin Pharmacol 1973;13:61-67.
6. Yonkers KA, Kando JC, Cole JO, Blumenthal S: Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am J Psychiatry 1992;149:587-595.
7. Verbrugge LM: Females and illness: recent trends in sex differences in the United States. J Health Social Behav 1976;17:387-403.
8. Figueras A, Capella D, Castel JM, Laporte JR: Spontaneous reporting of adverse drug reactions to non-steroidal anti-inflammatory drugs: a report from the Spanish System of Pharmacovigilance, including an early analysis of topical and enteric-coated formulations. Eur J Clin Pharmacol 1994;47:297-303.
9. O'Donnell J: Adverse drug reactions. Legal Med 1994:229-267.
10. Lang DM, Alpern MB, Visintainer PF, Smith ST: Gender risk for anaphylactoid reaction to radiocontrast media. J Allerg Clin Immunol 1995;95:813-817.
11. Harris RZ, Benet LZ, Schwartz JB: Gender effects in pharmacokinetics and pharmacodynamics. Drugs 1995;50:222-239.
12. Patented Medicine Prices Review Board: Anatomical Therapeutic Chemical (ATC) Classification System for Human Medicines. Canadian edition. Ottawa, Health Canada, 1995.
13. Dukes MNG (ed.): Meyler's Side Effects of Drugs: An Encyclopedia of Adverse Reactions and Interactions. Twelfth edition. New York: Elsevier Science, 1992.
14. Bennett BS, Lipman AG: Comparative study of prospective surveillance and voluntary reporting in determining the incidence of a adverse drug reactions. Am J Hosp Pharm 1977;34:931-936.
15. Hurwitz N: Predisposing factors in adverse reactions to drugs. Br Med J 1969;1:536-539.
16. Miller RR: Drug surveillance utilizing epidemiologic methods: a report from the Boston Collaborative Drug Surveillance Program. Am J Hosp Pharm 1973;30:584-592.
17. Grymonpre RE, Mitenko PA, Sitar DS, Aoki FY, Montgomery PR: Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc 1988;36:1092-1098.
18. Domecq C, Naranjo CA, Ruiz I, Busto U: Sex-related variations in the frequency and characteristics of adverse drug reactions. Int J Clin Pharmacol 1980;18:362-366.
19. Bottiger L: Adverse drug reaction: an analysis of 310 consecutive reports to the Swedish Drug Reaction Committee. J Clin Pharmacol 1973;13:373-382.
20. Olgilvie RI, Ruedy J: Adverse drug reactions during hospitalization. Can Med Assoc J 1967;97:1450-1457.
21. Vakil B, Kulkarni R, Chabria N: Intense surveillance of adverse drug reactions: an analyses of 338 patients. J Clin Pharmacol 1975;15:435-441.
22. Albano JDM, Campbell SK, Farrer A, Millar JGB: Gender differences in urinary kallikrein excretion in man: variation throughout the menstrual cycle. Clin Sci 1994;86:227-232.
23. Wald A, Van Thiel DH, Hoechstetter L, Gavaler JS, Egler KM, Verm R, et al: Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology 1981;80:1497-1500.
24. Reister EF, Pantuck EJ, Pantuck CB, Passananti GT, Vesell ES, Conney AH: Antipyrine metabolism during the menstrual cycle. Clin Pharmacol Ther 1980;28:384-391.
25. Cleary PD, Mechanic D, Greenley JR: Sex differences in medical care utilization: an empirical investigation. J Health Social Behav 1982;23:106-119.
26. Hibbard JH, Pope CR: Gender roles, illness orientation and use of medical services. Social Sci Med 1983;17:129-137.
27. Svarstad B, Cleary P, Mechanic D, Robers P: Gender differences in the acquisition of prescribed drugs: an epidemiological study. Med Care 1987;25:1089-1098.
28. Kando JC, Yonkers KA, Cole JO: Gender as a risk factor for adverse events to medications. Drugs 1995;50:1-6.
29. Lexchin J. Adverse drug reactions: review of the Canadian literature. Can Fam Physician 1991:37:109-118.
30. Statistics Canada: Industry Canada Health Reports. Report no. 82-567. 1997.
31. Verbrugge LM, Steiner RP: Physician treatment of men and women patients. Med Care 1981;19:609-632.
32. Verbrugge LM: Sex differences in complaints and diagnoses. J Behav Med 1980;3:327-355.
33. Blanca M, Vega J, Garcia J, Carmana MJ, Terrados S, Avila MJ, et al: Allergy to penicillin with good tolerance to other penicillins: study of incidence in subjects allergic to beta-lactams. Clin Exp Allerg 1990;20:475-481.
34. Gadde J, Spence M, Wheeler B, Adkinson N: Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA 1993;270:2456-2463.
35. Macy E, Richter PK, Falkoff R, Zeiger R: Skin testing with penicilloate and penilloate prepared by an improved method: amoxicillin oral challenge in patients with negative skin test responses to penicillin reagents. J Allerg Clin Immunol 1997;100:586-591.
36. Sogn D, Evans R, Shepherd G, Casale TB, Candeni J, Greenberger PA, et al: Results of the National Institute of Allergy and Infectious Disease collaborative clinical trial to test the predictive value of skin with major and minor penicillin derivatives in hospitalized adults. Arch Intern Med 1992;152:1025-1032.
37. Mackenzie D, Williams B, Single E: Canadian Profile: Alcohol, Tobacco, and Other Drugs. Canadian Centre on Substance Abuse, Addiction Research Foundation of Ontario, Toronto, 1997.